Veterinary Molecular Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Kit and Reagents, Software and Services), By Application (Infectious Diseases, Genetics, Other), By Technology (PCR, Microarray, DNA Sequencing), By Region and Competition, 2020-2030F

December 2025 | 182 pages | ID: VD230065CC04EN
TechSci Research

Abstracts

The Global Veterinary Molecular Diagnostic Market, valued at USD 1.19 Billion in 2024, is projected to experience a CAGR of 8.90% to reach USD 1.98 Billion by 2030. The Global Veterinary Molecular Diagnostic Market involves the utilization of specialized laboratory techniques to analyze an animal's DNA, RNA, or other proteins for the accurate detection, identification, and genotyping of diseases or genetic predispositions. Market growth is primarily driven by the increasing prevalence of infectious animal diseases globally, rising companion animal ownership, and the sustained demand for safe, animal-derived food products.

Key Market Drivers

The global veterinary molecular diagnostic market is significantly influenced by the increased prevalence of animal diseases, which necessitates advanced and rapid detection methods to mitigate health and economic impacts. The continuous emergence and spread of infectious diseases across diverse animal populations, including both livestock and companion animals, underscore a critical need for precise diagnostic capabilities.

Key Market Challenges

The substantial cost associated with developing, producing, and maintaining advanced molecular diagnostic technologies and their associated testing presents a significant impediment to the growth of the Global Veterinary Molecular Diagnostic Market. This financial burden directly limits the accessibility of these crucial tools for many veterinary practices, particularly smaller clinics or those operating in regions with constrained budgets. The significant upfront investment required for purchasing specialized equipment, coupled with ongoing expenses for reagents, consumables, and the continuous professional development needed for staff, creates a formidable barrier to adoption.

Key Market Trends

The shift towards point-of-care molecular diagnostics represents a significant evolution in veterinary medicine, enabling veterinarians to perform advanced tests directly at the animal's location or within the clinic. This trend reduces turnaround times for results, facilitating immediate treatment decisions and improving patient outcomes. Such accessibility is particularly crucial for time-sensitive conditions and in remote settings where centralized laboratories are not readily available.

Key Market Players

• Biochek BV
• Biomerieux SA
• Bioneer Corporation
• Idexx Laboratories Inc.
• Ingenetix GmbH
• Neogen Corporation
• Thermo Fischer Scientific Inc.
• Veterinary Molecular Diagnostics Inc.
• Biomedica Medizinprodukte GmbH
• Novacyt Group

Report Scope:

In this report, the Global Veterinary Molecular Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Veterinary Molecular Diagnostic Market, By Product:
• Instruments
• Kit and Reagents
• Software and Services
• Veterinary Molecular Diagnostic Market, By Application:
• Infectious Diseases
• Genetics
• Other
• Veterinary Molecular Diagnostic Market, By Technology:
• PCR
• Microarray
• DNA Sequencing
• Veterinary Molecular Diagnostic Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Veterinary Molecular Diagnostic Market.

Available Customizations:

Global Veterinary Molecular Diagnostic Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Instruments, Kit and Reagents, Software and Services)
  5.2.2. By Application (Infectious Diseases, Genetics, Other)
  5.2.3. By Technology (PCR, Microarray, DNA Sequencing)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Application
  6.2.3. By Technology
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Veterinary Molecular Diagnostic Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Application
      6.3.1.2.3. By Technology
  6.3.2. Canada Veterinary Molecular Diagnostic Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Application
      6.3.2.2.3. By Technology
  6.3.3. Mexico Veterinary Molecular Diagnostic Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Application
      6.3.3.2.3. By Technology

7. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Application
  7.2.3. By Technology
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Veterinary Molecular Diagnostic Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Application
      7.3.1.2.3. By Technology
  7.3.2. France Veterinary Molecular Diagnostic Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Application
      7.3.2.2.3. By Technology
  7.3.3. United Kingdom Veterinary Molecular Diagnostic Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Application
      7.3.3.2.3. By Technology
  7.3.4. Italy Veterinary Molecular Diagnostic Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Application
      7.3.4.2.3. By Technology
  7.3.5. Spain Veterinary Molecular Diagnostic Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Application
      7.3.5.2.3. By Technology

8. ASIA PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Application
  8.2.3. By Technology
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Veterinary Molecular Diagnostic Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Application
      8.3.1.2.3. By Technology
  8.3.2. India Veterinary Molecular Diagnostic Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Application
      8.3.2.2.3. By Technology
  8.3.3. Japan Veterinary Molecular Diagnostic Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Application
      8.3.3.2.3. By Technology
  8.3.4. South Korea Veterinary Molecular Diagnostic Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Application
      8.3.4.2.3. By Technology
  8.3.5. Australia Veterinary Molecular Diagnostic Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Application
      8.3.5.2.3. By Technology

9. MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Application
  9.2.3. By Technology
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Veterinary Molecular Diagnostic Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Application
      9.3.1.2.3. By Technology
  9.3.2. UAE Veterinary Molecular Diagnostic Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Application
      9.3.2.2.3. By Technology
  9.3.3. South Africa Veterinary Molecular Diagnostic Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Application
      9.3.3.2.3. By Technology

10. SOUTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Application
  10.2.3. By Technology
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Veterinary Molecular Diagnostic Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Application
      10.3.1.2.3. By Technology
  10.3.2. Colombia Veterinary Molecular Diagnostic Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Application
      10.3.2.2.3. By Technology
  10.3.3. Argentina Veterinary Molecular Diagnostic Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Application
      10.3.3.2.3. By Technology

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Biochek BV
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Biomerieux SA
15.3. Bioneer Corporation
15.4. Idexx Laboratories Inc.
15.5. Ingenetix GmbH
15.6. Neogen Corporation
15.7. Thermo Fischer Scientific Inc.
15.8. Veterinary Molecular Diagnostics Inc.
15.9. Biomedica Medizinprodukte GmbH
15.10. Novacyt Group

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER